REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,065,918 | -13.5% | 3,145,445 | -16.4% | 1.02% | -14.4% |
| Q2 2023 | $100,616,781 | +35.7% | 3,761,375 | +9.9% | 1.19% | +18.2% |
| Q1 2023 | $74,141,574 | +591.7% | 3,422,972 | +660.6% | 1.01% | +605.6% |
| Q4 2022 | $10,719,357 | -3.6% | 450,015 | -20.2% | 0.14% | -7.7% |
| Q3 2022 | $11,120,000 | +116.3% | 563,881 | +113.8% | 0.16% | +96.2% |
| Q2 2022 | $5,141,000 | -91.4% | 263,799 | -88.7% | 0.08% | -91.8% |
| Q1 2022 | $59,474,000 | -19.4% | 2,331,395 | -20.4% | 0.96% | -8.6% |
| Q4 2021 | $73,749,000 | +208.3% | 2,930,038 | +237.0% | 1.06% | +170.1% |
| Q3 2021 | $23,920,000 | -11.5% | 869,484 | +2.1% | 0.39% | -22.4% |
| Q2 2021 | $27,030,000 | -30.0% | 851,592 | +1.1% | 0.50% | -41.2% |
| Q1 2021 | $38,634,000 | +20.9% | 842,062 | +4.3% | 0.86% | +1.2% |
| Q4 2020 | $31,954,000 | +3190.8% | 807,130 | +2791.8% | 0.85% | +2546.9% |
| Q3 2020 | $971,000 | -19.2% | 27,911 | -49.1% | 0.03% | -62.8% |
| Q1 2020 | $1,202,000 | – | 54,867 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |